4.6 Article

TREM2 Agonism with a Monoclonal Antibody Attenuates Tau Pathology and Neurodegeneration

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Exosomal and vesicle-free tau seeds-propagation and convergence in endolysosomal permeabilization

Juan Carlos Polanco et al.

Summary: The study investigates the propagation mechanisms of tau seeds in Alzheimer's disease and proposes potential methods to control their spread by manipulating mechanisms. It emphasizes the ability of tau seeds to trigger endolysosomal permeabilization and suggests targeting the endolysosomal pathway as a key to developing broad-spectrum treatments for neurodegenerative diseases.

FEBS JOURNAL (2022)

Article Immunology

Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models

Michael Fassler et al.

Summary: A novel monoclonal antibody targeting membrane-bound and soluble TREM2 has been developed, which improves cognitive function by inducing microglial activation and attenuating chronic neuroinflammation, showing potential for clinical applications in vitro and in vivo.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Neurosciences

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology

Seung-Hye Lee et al.

Summary: Loss-of-function TREM2 mutations increase Alzheimer's disease risk. TREM2 deletion has protective functions in beta-amyloid and tau pathologies; in the presence of beta-amyloid pathology, Trem2 deletion exacerbates tau accumulation and spreading, promoting neurodegeneration. TREM2 may slow AD progression and reduce tau-driven neurodegeneration by limiting beta-amyloid's facilitation of pathogenic tau spreading.

NEURON (2021)

Review Neurosciences

Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies

Narendran Annadurai et al.

Summary: The spread of tau pathology in AD mainly occurs through a prion-like manner between cells. The secretion pathway of tau involves unconventional secretory pathways, such as non-vesicular and vesicular mechanisms, leading to tau release into the extracellular space. Further research is needed to understand these pathways for the development of therapeutic approaches targeting prion-like tau forms in AD.

EXPERIMENTAL NEUROLOGY (2021)

Article Medicine, Research & Experimental

Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region

Kai Schlepckow et al.

EMBO MOLECULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway

Aleksandra Deczkowska et al.

Article Neurosciences

TREM2 function impedes tau seeding in neuritic plaques

Cheryl E. G. Leyns et al.

NATURE NEUROSCIENCE (2019)

Article Geriatrics & Gerontology

Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's disease

Edmond Teng et al.

NEUROBIOLOGY OF AGING (2019)

Article Multidisciplinary Sciences

Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy

Faten A. Sayed et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Neurosciences

Different tau species lead to heterogeneous tau pathology propagation and misfolding

Simon Dujardin et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Article Neurosciences

TREM2 variants: new keys to decipher Alzheimer disease pathogenesis

Marco Colonna et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Article Biochemistry & Molecular Biology

TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model

Yaming Wang et al.

Article Biochemical Research Methods

Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex

Gerard M. J. Beaudoin et al.

NATURE PROTOCOLS (2012)